Introduction: Nasopharyngeal carcinoma (NPC) has the propensity to develop distant metastases at a high rate and with poor prognosis. The metastatic sites are usually multifocal and involve the bones, lungs, liver and distant lymph nodes. The management of metastatic disease is essenti-ally palliative and is based on radiochemotherapy. Methods: A 50-year old man with a huge hematoma in the liver derived from a diagnosed NPC was treated with intermittent drainage of the hepatic hematoma for abdominal decompression, and the cavity was packed with omentum. In addition, 2 suspected metastatic lesions were excised. Neoadjuvant radiochemotherapy followed by concurrent chemotherapy was administered. Results: After surgical treatment of the huge hematoma, the suspect sites in the liver were diagnosed as metastatic carcinoma, similar to the primary tumor. Several months later, bone metastatic lesions in the vertebra and oss iliaca dextra were detected due to distant metastasis. Conclusion: Treatment of metastatic NPC is essentially palliative and survival is usually poor.
INTRODUCTION
N asopharyngeal carcinoma (NPC) is a squamous cell carcinoma arising from the epithelium of the nasopharynx. NPC accounts for 70% of nasopharyngeal malignancies and represents 0.25% of all malignancies in Caucasian patients. These neoplasm are much more common in patients of southern Chinese origin, with an incidence of 18 per 100,000, whereas in western countries, the incidence is less than 1 per 100,000 1, 2 . There is a strong indication of viral origin, as elevated titers of Epstein-Barr virus antibodies are found in almost all patients with advanced NPC 3 .
The incidence of NPC is 1 per 100,000 men and 0.4 per 100,000 women 1 . NPC affects men more often than it does women. Patients are typically in the sixth decade of life 4 . The World Health Organization (WHO) classifies epithelial NPCs into 2 subtypes depending on whether the squamous cell carcinoma is keratinizing (type 1) or nonkeratinizing (type 2). The latter is further subdivided into differentiated (2a) and undifferentiated (undifferentiated carcinoma of nasopharyngeal type) (2b) forms. As nasopharyngeal squamous cell carcinoma is often heavily infiltrated with lymphocytes, subtypes 2a and 2b are often termed lymphoepitheliomas 5 .
CASE REPORT
In 1999, a 50-year-old man was treated for a retropharyngeal abscess. During a routine abdominal ultrasonography in 2008, 2 solid cystic lesions were detected in the liver, in segments 3 and 6. A computed tomography (CTscan) confirmed the ultrasonography findings. The sizes of the lesions in segments 3 and 6 were 7 x 4 cm and 5 x 4 cm, respectively. On the basis of their size, the lesions were considered metastases; however, this interpretation was reserved because of the primary carcinoma was not detected. Accordingly, the lesions were considered suspicious with the main diagnosis of echinococcosis, but follow-up surveillance was recommended.
During the last months of 2009, a swelling appeared on the left side of the patient's neck. Histological examination revealed an undifferentiated type of NPC. In JanuaryFebruary 2010, the patient was treated with local radiation therapy combined with chemotherapy, consisting of cisplatin, 5 
rezime
The next CT scan showed that the lesions in the liver were reduced and appeared as clear cysts without a solid component, with dimensions of 4.5 x 3.5 cm and 5 x 4.5 cm in segments 3 and 6, respectively. This result confirmed the effectiveness of chemotherapy on the suspicious lesions and was a strong incentive to reconsider their metastatic nature.
In July 2010, the patient complained of abdominal fullness, poor appetite, and general weakness. He was admitted to the hospital for further treatment. During hospitalization, physical examinations showed an ovoid shape in the abdomen with tenderness. A CT scan revealed a huge cystic lesion in the liver localized in segments 4, 5, and 6 (dimension 16 cm x 14 cm). The patient underwent intermittent drainage of the huge hepatic hematoma lesion for abdominal decompression, and the cavity was packed with omentum ( Fig.1 ). Adequate analgesia with psychological treatment was administered continuously. In addition, a biopsy of the 2 site lesions was performed. Histological examination revealed a metastatic carcinoma with morphological and immunophenotypical characteristics similar to those of the primary tumor. After the intervention, the patient underwent concurrent chemotherapy with cisplatin and 5-FU.
After treatment, the condition of the patient was aggravated, and 3 months later, another CT scan showed a metastatic bone lesion in thoracic vertebra 11, lumbar vertebra 1, and in the oss iliac dextra (Fig.2 & 3) .
DISCUSSION
The reported incidence of distant metastases arising from NPC ranges from 17% to 54% 6 . The bone, lung, liver, and distant lymph nodes are the most common sites of distant metastases 7 . The liver is the third most frequent site of metastasis, with an incidence of 29.3 -38% 6, 8 . Cystic liver metastases are rare; they usually derive from colorectal cancer 9 and rarely from pancreatic, gastric, or lung cancer 10 . The cause of the cystic change in these secondary liver tumors is not well understood, but this change could be induced by many factors, such as infectious or congenital diseases, liver injuries, benign tumors, or liver metastasis of other malignant tumors (e.g., carcinoid, ovary, and pancreas). The hemorrhage and necrosis usually present in these lesions are believed indicate that the tumor has grown rapidly, outstripping its blood supply 11 . NPC with liver invasion usually presents as solitary or multiple solid tumor metastases 7 . The distant metastasis in NPC has remained the major cause of mortality and treatment failure, despite better locoregional control of the disease 12 . Advanced locoregional and nodal disease is strongly correlated with poor prognosis and high incidence of metastatic disease 6 . Median survival time after the development of metastasis is reported to be 8 months 7 , whereas some series report a disease-free survival rate ranging between 82 and 190 months 13 . Poly-chemotherapy can be considered as the standard of care in patients with metastatic NPC 14 . Cisplatin-based combination chemotherapy is the most effective standard treatment for metastatic NPC 15 . The combination of cisplatin and infusional 5-FU remains the most commonly used first-line treatment, with a 66-76% response rate 16 . More intensive combinations elicit a higher response rate, but are also usually associated with increased toxicities. None of these combinations have been directly compared with the combination of cisplatin and 5-FU yet 17 . Twenty long-term (more than 36 months) disease-free survivors of metastatic NPC (bone, lung, or liver) from the Institut Gustave-Roussy have been reported to receive This suggests a potential curative role for chemotherapy in metastatic NPC and provides a major incentive for continued research to determine more effective combination chemotherapies with a view to increasing the percentage of patients who attain complete responses and long-term survival 13 .Hepatic resection is an effective and potentially curative procedure for patients with liver metastases from colo-rectal and neuroendocrine malignancies, with a 5-year su-rvival rate of 30-51% and 50-76%, respectively, accor-ding to various studies 18 . The Memorial Sloan-Kettering group 18 has reported 2 cases of liver resection for metastases from NPC with long-term outcomes. Similar results were reported by Elias et al. in 5 patients with head and neck tumors who had undergone liver resection 19 .Another method for early detection of distant metastases of NPC is positron emission tomography using fluorine-18-labeled fluorodeoxyglucose 20 . This method was not used in this case. However, early detection of further liver metastases might not have changed clinical management nor improved patient survival 21 . The prognosis of patients with liver metastasis is considered to be poorer than those of patients with lung or bone metastasis 22 . In conclusion, the treatment of metastatic NPC is essentially palliative, despite several treatments with radi-ochemotherapy or surgery, and the survival is usually poor. Palliative treatment is important in reducing the patient's discomfort and improving the quality of life.
SUMMARY NEUOBI^AJENA PREZENTACIJA NAZOFARINGEAL-NOG KARCINOMA U VIDU VELIKOG HEMATOMA JETRE
Nazofaringealni karcinom ima veliku sklonost da da udaljene metastaze i ima lo{u prognozu. Obi~no se radi o multifokalnim metastazama, koje mogu zahvatiti kosti, plu}a, jetru i udaljene limfne ~vorove. Tretman ovih metastaza je uglavnom palijativan i baziran na radiohemioterapiji. Metode: pedesetogodi{nji pacijent sa velikim hematomom jetre i dijagnozom nazofaringealnog karcinoma tretiran je intermitentnim drena'ama navedenog hematoma u cilju abdominalne dekompresija i kavum je napunjem omentumom. Pored toga, 2 suspektne metastatske promene su ekscidirane. Nakon toga je ordinirana neoadjuvantna radiohemioterapija i hemioterapija. Rezultati: posle hirur{kog tretmana ovog velikog hematoma, suspektne promene u jetri su dijagnostikovane kao metastatski karcindomi, sli~no primarnom tumoru. Nekoliko meseci kasnije, otkrivene su metastaze u kostima ki~menog stuba i desnoj ilija~noj kosti. Zaklju~ak: tretman metastaza nazofaringealnog karcinoma je palijativan i pre'ivljavanje je uglavnom lo{e.
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